Chorea-acanthocytosis
Definition
Chorea-acanthocytosis (ChAc) is a very rare, hereditary neurodegenerative disorder. The characteristic features of the condition are problems with movement and star-shaped red blood cells.
The condition occurs due to a genetic alteration that affects a protein known as chorein. The variation causes this protein to be much smaller and nonfunctional. However, researchers are currently unsure how this genetic change causes the symptoms of ChAc. At present, there is no cure for ChAc, but many treatment options are available to help relieve symptoms.
ChAc is a type of Trusted Source neuroacanthocytosis. This term refers to a group of conditions that cause movement problems and star-shaped red blood cells. ChAc is a rare condition. Evidence suggests that only 500 to 1,000 people worldwide have the condition.
What is chorea?
Chorea refers to the specific type of jerking, twitching, or dance-like movements that occur in people with ChAc. Health experts define chorea Trusted Source as a state of spontaneous, exaggerated movements that:
do not have regular timing
are not repetitive in nature
happen randomly
usually start and finish abruptly
This condition is also known as VPS13A disease Trusted Source, named after the gene that causes it to develop. Chorea can range from mild to severe.
Mild chorea comes and goes, causing uncontrollable fidgeting with the hands and exaggerated gestures and facial expressions. Severe chorea can lead to continuous, violent, involuntary movements that significantly interfere with daily function.
What is acanthocytosis?
Acanthocytosis is a condition that causes Trusted Source the formation of star-shaped red blood cells. It occurs when the proteins and fatty substances that make up the outer layers of cells undergo changes. These changes usually develop in people with severe liver problems, malnutrition, and low activity in the thyroid glands.
Certain conditions, such as neuroacanthocytosis, can lead to these abnormal cells. The name comes from the spikes or points called acanthocytes Trusted Source that develop on the outside of the cells. This shape may affect how the cells work as well as their ability to pass through the smallest blood vessels.
Symptoms
Chorea is the main symptom of ChAc. This involves unwanted movements, usually affecting the arms and legs. These movements might include sporadic shoulder shrugs, pelvic thrusts, and a lurching walking style that includes involuntary knee flexing.
These symptoms often begin when a person is an adult and get worse over time. Other movement-based symptoms might include Trusted Source repeatedly dropping objects or repeatedly squeezing and releasing them while attempting a single gripping motion.
Dystonia is another common ChAc symptom. This involves involuntary muscle contraction and the contraction of certain body parts into atypical movements and postures. In those with ChAc, dystonia of the mouth and face are common.
Other common symptoms include:
nerve damage, leading to numbness and loss of reflexes
muscle wasting
weakness
seizures
Rarely, people with ChAc may develop symptoms that resemble those of Parkinson’s disease, including stiffness, tremors, and quiet speech.
Facial symptoms
When dystonia and chorea occur in the faces of people with ChAc, they can cause:
tongue thrusting
involuntary grimacing
unusual jaw movements
uncontrollable grinding of the teeth
excessive belching, spitting, or drooling
regularly biting the lips or tongue
swallowing difficulties
speech and communication difficulties
vocal tics including grunts and involuntary speech
slurred speech
Cognitive, personality, and behavioral symptoms
These may develop later on in the progression of ChAc. People with ChAc can experience:
apathy
depression
hyperactivity
irritability
slow thought processes
extreme mood changes
anxiety
aggression
paranoia
compulsive behaviors such as chronic hair-pulling
Causes
ChAc develops due to changes in the VPS13A gene. This gene has links to the body’s ability to make a protein called chorein. Although this protein’s function is not clear, chorein proteins are unusually small and do not work correctly in people with ChAc.
ChAc passes from parents to children in an autosomal recessive pattern. This means that a copy of the VPS13A gene variation has to pass down from each parent. If a person only has one copy, they can still pass on the condition to their own offspring as a carrier. If they have a child with another carrier, the child may have the gene alteration and develop acanthocytosis.
Complications
ChAc can eventually become so severe that some people with the condition develop the following complications:
a lost ability to walk independently, meaning they remain in bed or require a wheelchair
mutilation of the lips and tongue due to excessive involuntary biting
muteness or an inability to speak
dementia and progressive memory problems
A person with advanced ChAc may not be able to care for themselves.
Diagnosis
There are no set diagnostic criteria Trusted Source for ChAc. Diagnosing ChAc involves ruling out conditions with similar symptoms, such as Huntington disease, and checking the blood for signs of acanthocytosis. This may involve:
a detailed medical examination to identify its main symptoms
blood tests, which often show high serum creatine kinase levels
genetic testing, which can show changes to the VPS13A gene
MRI and CT scans, which can show brain changes
electromyography (EMG), which can demonstrate muscle and nerve function and identify problems
TreatmentCurrently, there is no cure for ChAc. However, several treatments can help people manage individual symptoms, preserve function, and maintain quality of life.
Psychiatric symptom management and chorea treatment
Dopamine-receptor blocking drugs play a role in reducing chorea movements, as dopamine is crucial for brain functions including movement control.
People with ChAc might also benefit from using additional medications when symptoms arise, such as:
antipsychotics
antidepressants
sedatives
Seizure treatment
Almost half of all people with ChAc live with regular seizures and may need to take anticonvulsants such as phenytoin and valproate. However, some antiseizure medications may make chorea worse and might not be suitable for some people with ChAc.
Dystonia treatment
Botulinum toxin (Botox) injections may help people reduce or resolve muscle spasms due to dystonia. The effects may take 5 to 10 days, and people may need to have another injection every 3 to 4 months.
Nutritional support
As people with ChAc may have difficulty chewing and swallowing food, it is vital for people to monitor their nutritional status. They may need support from a dietitian or nutritionist. Individuals with ChAc may also need to supplement vitamins and minerals if they have low levels.
Doctors may insert feeding tubes for people with severe ChAc who can no longer eat.
Therapies to assist with daily function
Speech, physical, and occupational therapists may help preserve or restore a person with ChAc’s ability to move, speak, and work. Not every person will need these services, and a doctor will adjust their recommendations based on which symptoms interfere most with everyday function, as well as the stage of progression.
People may also benefit from using certain devices. A mouth guard can help limit damage to the tongue and lips from involuntary biting. Braces may support limb stability, and people may need a wheelchair to move around.
Computer-assisted speech devices can support communication in everyday life for people with ChAc.
Deep brain stimulation
People with ChAc might benefit from a surgical procedure called deep brain stimulation. A surgeon places an electrode in the brain and a small battery pack near the collarbone to control movements and block disruptive nerve signals that could have links to chorea and dystonia.
Genetic counseling
Genetic counseling may be beneficial for affected individuals and their families. It can help people with ChAc work out the risk of passing on the VPS13A gene and whether offspring might develop the condition.
Summary
Chorea-acanthocytosis is a rare type of neuroacanthocytosis. It causes brain and central nervous system symptoms as well as star-shaped red blood cells called acanthocytes. The main symptoms are chorea, which involves involuntary muscle movements, and dystonia, which leads to muscles staying contracted. Seizures and behavioral symptoms are also common.
The condition develops due to alterations in a gene called VPS13A. At present, there is no cure, and the disease can progress to a point where individuals can no longer eat, speak, or move unassisted. However, medications, devices, and various therapies can reduce the impact of chorea-acanthocytosis on everyday function.
Type of Doctor Department : A neurologist, geneticist, and possibly a psychiatrist or neuropsychiatrist.
Comments
Post a Comment